Hanmi Pharm. Co.. Ltd.
Hanmi Pharm. Co.. Ltd. is a Private limited company (Ltd.) registered in South Korea under 1248700613, and its current status with Supreme Court Internet Registry (IROS) is active. Its registered address on file is Hwaseong-si, South Korea. 5 shareholders are on record for Hanmi Pharm. Co.. Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Supreme Court Internet Registry (IROS) and was last updated on 28 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Hanmi Pharm. Co.. Ltd., filed with Supreme Court Internet Registry (IROS).
The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 26% — the largest recorded stake — followed by Victory Portfolios-Victory Trivalent International Small Cap Fund at 9.2%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 10 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 26% | Supreme Court Internet Registry (IROS) | |
| Victory Portfolios-Victory Trivalent International Small Cap Fund | 9.2% | Supreme Court Internet Registry (IROS) | |
| iShares MSCI Emerging Markets ETF | 5.6% | Supreme Court Internet Registry (IROS) | |
| DFA Emerging Markets Core Equity Portfolio | 4.7% | Supreme Court Internet Registry (IROS) | |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 4% | Supreme Court Internet Registry (IROS) |
Officers
5
The Csr Executive Director of Hanmi Pharm. Co.. Ltd. currently on record is Jong-ho Lim; five officers are currently on record for Hanmi Pharm. Co.. Ltd., filed with Supreme Court Internet Registry (IROS).
The register reports 7 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Hanmi Pharm. Co.. Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Hanmi Pharm. Co.. Ltd. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span South Korea, China jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Hanmi Pharm. Co.. Ltd.
South Korea
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Hanmi Pharm. Co.. Ltd.?
Five shareholders are currently on record for Hanmi Pharm. Co.. Ltd., filed with Supreme Court Internet Registry (IROS). The largest of these is Vanguard International Stock Index-Total Intl Stock Indx, holding 26% — the largest recorded stake — followed by Victory Portfolios-Victory Trivalent International Small Cap Fund at 9.2%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Hanmi Pharm. Co.. Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Hanmi Pharm. Co.. Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Hanmi Pharm. Co.. Ltd. have on record?
5 shareholders are shown on record for Hanmi Pharm. Co.. Ltd.. The register reports 10 in total; only the top 5 by holding are shown here.
What is Hanmi Pharm. Co.. Ltd.'s company registration number?
Hanmi Pharm. Co.. Ltd.'s registration number is 1248700613, filed with Supreme Court Internet Registry (IROS) in South Korea. Its current status on the register is active.
Is Hanmi Pharm. Co.. Ltd. still an active company?
Hanmi Pharm. Co.. Ltd.'s status on Supreme Court Internet Registry (IROS) is listed as active.
What is Hanmi Pharm. Co.. Ltd.'s registered address?
The registered address on file for Hanmi Pharm. Co.. Ltd. is Hwaseong-si, South Korea.
What legal structure is Hanmi Pharm. Co.. Ltd. registered as?
Hanmi Pharm. Co.. Ltd. is registered as a Private limited company (Ltd.) in South Korea.
Who are the officers/directors of Hanmi Pharm. Co.. Ltd.?
The Csr Executive Director of Hanmi Pharm. Co.. Ltd. currently on record is Jong-ho Lim; five officers are currently on record for Hanmi Pharm. Co.. Ltd., filed with Supreme Court Internet Registry (IROS). Management authority at Hanmi Pharm. Co.. Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Hanmi Pharm. Co.. Ltd. have a parent company or subsidiaries?
Hanmi Pharm. Co.. Ltd. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Those 2 subsidiaries span South Korea, China jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Hanmi Pharm. Co.. Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from Supreme Court Internet Registry (IROS). Zavia's monitoring API can track changes to Hanmi Pharm. Co.. Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Hanmi Pharm. Co.. Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including South Korea, so records like Hanmi Pharm. Co.. Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Supreme Court Internet Registry (IROS) and was last synced on 28 September 2026.